PATHOLOGYKi67, a marker of cellular proliferation, is commonly assessed in surgical pathology laboratories. In breast cancer, Ki67 is an established prognostic factor with higher levels associated with worse long-term survival. However, Ki67 IHC is considered of limited clinical use in breast cancer ...
向上滑动阅览 1) Penault-Llorca F, Radosevic-Robin N. Ki67 assessment in breast cancer: an update. Pathology. 2017 Feb;49(2):166-171. 2) Nielsen TO, Leung SCY, Rimm DL, et al. Assessment of Ki67 in Breast Cancer: Updated Recommendat...
[2]Skjervold AH, Pettersen HS, Valla M, et al. Visual and digital assessment of Ki-67 in breast cancer tissue-a comparison of methods[J]. Diagn Pathol, 2022, 17: 45. [3]Li L, Han D, Yu Y, et al. Arti...
Objectives: To evaluate Ki67 immunoexpression pattern in Saudi breast cancer (BC) patients and investigate any possible predictive or prognostic value for Ki67. Methods: This is a retrospective study designed to quantitatively assess the Ki67 proliferative index (PI) in retrieved paraffin blocks of 115...
Breast carcinoma is most common malignant tumour and leading cause of cancer death in women worldwide. Ki67 has a prediction of prognosis in breast carcino... SS Nigudgi,AG Patil,Shabnam,... - 《Indian Journal of Pathology & Oncology》 被引量: 0发表: 2019年 PCNA and Ki-67 expression in...
[Key words] Ki67;Expression;Breast cancer;Neoadjuvant chemotherapy;Relationship 乳腺癌是肿瘤科临床常见病、多发病,其治疗越来越受到人们的重视。目前治疗方法多为:术前化疗-手术切除-术后化放疗,新辅助化疗(neoadjuvant chem-otherapy,NC)指术前化疗。NC能缩小肿瘤体积,还可降低区域淋巴结分期,利于患者预后。Ki67与...
[Key words] Ki67;Expression;Breast cancer;Neoadjuvant chemotherapy;Relationship 乳腺癌是肿瘤科临床常见病、多发病,其治疗越来越受到人们的重视。目前治疗方法多为:术前化疗-手术切除-术后化放疗,新辅助化疗(neoadjuvant chem-otherapy,NC)指术前化疗。NC能缩小肿瘤体积,还可降低区域淋巴结分期,利于患者预后。Ki67与...
Introduction: In cases of breast cancer, in addition to hormone receptor and Her2 status, proliferation markers (mitotic index, Ki-67 proliferation index = KIPI) also have therapeutic implications. The 2013 St. Gallen consensus guideline ...
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue Background Metadherin (MTDH) has been reported to be associated with cancer progression in various types of human cancers including breast cancer. Whether ... P Su,Q Zhang,Q Yang - 《Diagnostic Pathology》 被引量...
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. It is widely believed that ductal breast cancer dissemination involves a succession of clinical and pathological stages starting with carcinoma in situ, pr... Lacroix,R-A,Toillon,... - Endocrine-rela...